Navigation Links
Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
Date:11/2/2007

key scientists or management personnel, and other factors that are described in the "Risk Factors" section (Part II, Item 1A) of Vanda's report on Form 10-Q for the quarter ended June 30, 2007 (File No. 000-51863). No forward-looking statements can be guaranteed and actual results may differ materially from such statements. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...E, Fla. -- A Florida State University College of M...covered an important new layer of regulation in th...er understanding of the way cancer begins. , Wan...t the College of Medicine, said the findings will ... could lead to the design of new drugs that kill c...
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...h a pound of cure.' -Henry de Bracton – A disea...cause the deepest anguish is preventable. It is no...entable. Sunday, 4 February 2007, is World Cancer ...ying the theme - “Today’s Children, Tomorrow’s Wor...
... loss of muscle tone in the body, which occurs dur...r or anger. Cataplexy is one of the symptoms of// ... asleep. In narcolepsy there are compulsive sleep...tible urge to sleep even in the most unlikely circ...
...nt sports in the world, has continued to grow in p...hildren participating in organized and// unorganiz... children at risk for injury. A study conducted by...d Policy (CIRP) at Columbus Children’s Hospital is...
...new weapon is being investigated.// Scientists ha...nt -oligo fructose, on obese human subjects. The...ural fiber seen in baby foods, cereals and yogurt ... on genetically obese lab rats. Reportedly, oligo...
Other Medicine News:Health News:'Cancer Prevention' - In Your Hands 2Health News:'Cancer Prevention' - In Your Hands 3Health News:Cataplexy During Status Cataplecticus Resembles REM Sleep 2Health News:Study Reveals 1.6 Million Pediatric Soccer Injuries 2
(Date:11/20/2008)...-FirstCall/ -- PAREXEL International Corporation (...al services provider, today announced that it has ...ry consulting and clinical research capabilities. ...has locations throughout five important biopharmac...de Argentina, Brazil, Chile, and Mexico. This expa...
(Date:11/19/2008)...chieve statistical significance , , ISELIN,...Corporation (Nasdaq: PARS ) today announced resu...l NanoEmulsion (NE) drug delivery technology formu... The multi-center, randomized, double-blinded, pl...ficacy of the Company,s 3% Diclofenac Diethanolami...
(Date:11/19/2008)...t from Roche- , , MONTVALE, N.J., Nov. 19 /...rp. (Nasdaq: MEMY ) today announced that it has ... of R3487/MEM 3454, its lead alpha-7 nicotinic rec...with schizophrenia (CIAS). The Company has random... a $5.0 million payment from its partner Roche. M...
(Date:11/18/2008)...Newswire-USNewswire/ -- Forty-two leading U. S. sc...tional forum to consider cutting-edge innovations ...al economy from outbreaks of dangerous zoonotic di... Among those innovations: , , , , ...le that detects highly contagious and dangerous zo...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 1Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 2Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 3Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 4Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 5iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 1iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 2iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 3Antibiotics May Not Cause Diarrheal Bacteria 27262 1Antibiotics May Not Cause Diarrheal Bacteria 27262 2Healthcare Resources Available in Difficult Times 27258 1Healthcare Resources Available in Difficult Times 27258 2Healthcare Resources Available in Difficult Times 27258 3
...Mass.--(BUSINESS WIRE)--Jun 8, 2007 - Archemix Cor... and developing,aptamers, announced the successful...r therapeutic, ARC1779. ARC1779 is designed to,sel...ation of,platelets by inhibiting the binding of vo...platelets. Activated vWF is scientifically,recogni...
...MARGIN: 0in 0in 0pt; LINE-HEIGHT: 150%; mso-hyphen...oneering nasal spray,could stop thousands of patie...t was reported today1 at the 10th Congress of,the ..., 7–9,June. The study investigated whether t... fast onset of pain relief and short,duration of e...
Other Medicine Technology:Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: